Company Profile | February 28, 2014

2014 CRO Leadership Awards Winner

microconstants logo

Categories Won:

  1. Quality

  2. Regulatory

  3. Innovation

 

Drug Life Cycle Stages:

Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3)

Main Service Areas:
Bioanalytical, Clinical, Preclinical

Services & Capabilities:
Regulated bioanalysis (method development, GLP validation, and sample analysis for small molecules,  macromolecules, and biomarkers), DMPK assays, metabolic stability, metabolite profiling &   identification, CYP/UGT induction, inhibition & identification, pharmacokinetic analysis

Therapeutic Areas:
Provide regulated bioanalysis, drug metabolism, and pharmacokinetic analysis services for all therapeutic areas

Gilbert N. Lam, PH.D.

president

“For more than 15 years, MicroConstants has aimed to function as an extension of our sponsors’ development teams. Constant  communication and active participation in our sponsors’ programs
has enabled us to suggest critical solutions to their analytical challenges, and anticipate their needs. We are so honored that our sponsors have acknowledged our efforts, and awarded us with high marks in the regulatory, quality, and innovation categories.”